Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | FBP1 | P09467 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | RECQL | P46063 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL186778 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRAKR1C3MAPTTDP1 | |
| Benzene SCHEMBL28222938 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRAKR1C3MAPTTDP1 | |
| SCHEMBL230809 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRAKR1C3MAPTTDP1 | |
| Acrolein SCHEMBL18954136 | 0.90 | ALDH1A1 (0.81) | ALDH1A1TSHRAKR1C3MAPTTDP1 | |
| Acrolein SCHEMBL18954135 | 0.90 | ALDH1A1 (0.81) | ALDH1A1TSHRAKR1C3MAPTTDP1 | |
| SCHEMBL13825216 | 0.89 | ALDH1A1 (0.80) | ALDH1A1TSHRAKR1C3MAPTTDP1 | |
| SCHEMBL11469894 | 0.87 | ALDH1A1 (0.77) | ALDH1A1TSHRAKR1C3MAPTTDP1 | |
| SCHEMBL11469893 | 0.87 | ALDH1A1 (0.77) | ALDH1A1TSHRAKR1C3MAPTTDP1 | |
| SCHEMBL11473022 | 0.82 | ALDH1A1 (0.69) | ALDH1A1TSHRAKR1C3NPC1RAB9A | |
| SCHEMBL11473020 | 0.82 | ALDH1A1 (0.69) | ALDH1A1TSHRAKR1C3NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 304 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3784707-B1 | STABLE POLYUREA MICROCAPSULE COMPOSITIONS | INT FLAVORS & FRAGRANCES INC (US) | 2025-12-24 | — | — | EP | claimed |
| US-20250235136-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-07-24 | — | — | US | claimed |
| CN-114026418-B | Improvements in or relating to organic compounds | 奇华顿股份有限公司 | 2024-07-26 | — | — | CN | claimed |
| US-20240197222-A1 | ORAL CARE FLAVOUR FOR IMPROVING HAPPINESS STATE AND METHOD OF ASSESSING | GIVAUDAN SA (CH) | 2024-06-20 | — | — | US | claimed |
| US-20240197183-A1 | ORAL CARE FLAVOUR FOR IMPROVING INVIGORATION STATE AND METHOD OF ASSESSING | GIVAUDAN SA (CH) | 2024-06-20 | — | — | US | claimed |
| US-20240173230-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2024-05-30 | — | — | US | claimed |
| EP-4347760-A1 | ORAL CARE FLAVOUR FOR IMPROVING HAPPINESS STATE AND METHOD OF ASSESSING | Givaudan SA (CH) | 2024-04-10 | — | — | EP | claimed |
| EP-4347761-A1 | ORAL CARE FLAVOUR FOR IMPROVING INVIGORATION STATE AND METHOD OF ASSESSING | Givaudan SA (CH) | 2024-04-10 | — | — | EP | claimed |
| EP-4319715-A1 | FRAGRANCE COMPOSITION | Givaudan SA (CH) | 2024-02-14 | — | — | EP | claimed |
| EP-4257663-A1 | FOOD CONTACT SURFACE SANITIZING LIQUID | The Procter & Gamble Company (US) | 2023-10-11 | — | — | EP | claimed |
| US-11603506-B2 | Product comprising a plastic container and a substance composition | SYMRISE AG (DE) | 2023-03-14 | — | — | US | claimed |
| WO-2022234154-A1 | ORAL CARE FLAVOUR FOR IMPROVING INVIGORATION STATE AND METHOD OF ASSESSING | GIVAUDAN SA (CH) | 2022-11-10 | — | — | WO | claimed |
| WO-2022234153-A1 | ORAL CARE FLAVOUR FOR IMPROVING HAPPINESS STATE AND METHOD OF ASSESSING | GIVAUDAN SA (CH) | 2022-11-10 | — | — | WO | claimed |
| US-20220334094-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2022-10-20 | — | — | US | claimed |
| WO-2022214636-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2022-10-13 | — | — | WO | claimed |
| WO-2022128052-A1 | MEDICAMENT FOR FIGHTING INFLAMMATORY CONDITIONS OF HUMAN SKIN | SYMRISE AG (DE) | 2022-06-23 | — | — | WO | claimed |
| EP-3990596-A2 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2022-05-04 | — | — | EP | claimed |
| CN-114026418-A | Improvements in or relating to organic compounds | 奇华顿股份有限公司 | 2022-02-08 | — | — | CN | claimed |
| EP-0404453-B1 | Dimer reduction | NOVA PETROCHEMICALS INC (CA) | 1994-02-23 | — | — | EP | claimed |
| EP-0067067-B1 | DRY-DEVELOPING NEGATIVE RESIST COMPOSITION | FUJITSU LIMITED (JP) | 1985-09-25 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240173230-A1 | FRAGRANCE COMPOSITION | FABP2, FABP5, FAAH2 | ALDH1A1 413/4885TSHR 4522/4885AKR1C3 2288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.